Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

ABC transporters as phenotypic markers and functional regulators of stem cells.

Bunting KD.

Stem Cells. 2002;20(1):11-20. Review. Erratum in: Stem Cells 2002;20(3):274.

2.

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Doyle L, Ross DD.

Oncogene. 2003 Oct 20;22(47):7340-58. Review.

PMID:
14576842
3.

ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.

Abbott BL.

Hematol Oncol. 2003 Sep;21(3):115-30. Review.

PMID:
14579240
4.

ABC transporters, neural stem cells and neurogenesis--a different perspective.

Lin T, Islam O, Heese K.

Cell Res. 2006 Nov;16(11):857-71. Review.

5.

The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival.

Krishnamurthy P, Schuetz JD.

Biometals. 2005 Aug;18(4):349-58. Review.

PMID:
16158227
6.

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Leslie EM, Deeley RG, Cole SP.

Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. Review.

PMID:
15845415
7.

Breast cancer resistance protein (BCRP) in acute leukemia.

Plasschaert SL, Van Der Kolk DM, De Bont ES, Vellenga E, Kamps WA, De Vries EG.

Leuk Lymphoma. 2004 Apr;45(4):649-54. Review.

PMID:
15160935
8.

Novel mechanisms of drug resistance in leukemia.

Ross DD.

Leukemia. 2000 Mar;14(3):467-73. Review.

PMID:
10720143
9.

The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

Assaraf YG.

Drug Resist Updat. 2006 Aug-Oct;9(4-5):227-46. Epub 2006 Nov 7. Review.

PMID:
17092765
10.

ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.

Abbott BL.

Clin Adv Hematol Oncol. 2006 Jan;4(1):63-72. Review.

PMID:
16562373
11.

[Drug resistance mediated by ABC transporters].

Yoshikawa M, Ito A, Ishikawa T, Ikegami Y.

Gan To Kagaku Ryoho. 2004 Jan;31(1):1-6. Review. Japanese.

PMID:
14750312
12.

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

Ahmed-Belkacem A, Pozza A, Macalou S, PĂ©rez-Victoria JM, Boumendjel A, Di Pietro A.

Anticancer Drugs. 2006 Mar;17(3):239-43. Review.

PMID:
16520651
14.
15.

Multidrug resistance: molecular mechanisms and clinical relevance.

Ling V.

Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8. Review.

PMID:
9272126
16.

[A novel marker of multiple drug resistance BCRP].

Bogush TA, Pokataev IA, Timofeeva NV, Ozherel'ev AS.

Antibiot Khimioter. 2003;48(6):33-41. Review. Russian.

PMID:
14558417
17.

[Drug-resistant proteins in breast cancer: recent progress in multidrug resistance].

Wu DL, Huang F, Lu HZ.

Ai Zheng. 2003 Apr;22(4):441-4. Review. Chinese.

PMID:
12704006
18.

Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.

Ejendal KF, Hrycyna CA.

Curr Protein Pept Sci. 2002 Oct;3(5):503-11. Review.

PMID:
12369998
19.

Effect of the breast-cancer resistance protein on atypical multidrug resistance.

Lage H, Dietel M.

Lancet Oncol. 2000 Nov;1:169-75. Review.

PMID:
11905655
20.

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

Steinbach D, Legrand O.

Leukemia. 2007 Jun;21(6):1172-6. Epub 2007 Apr 12. Review.

PMID:
17429427

Supplemental Content

Support Center